Literature DB >> 8256585

Proteins immunologically related to erythrocyte anion transporter band 3 are altered in brain areas affected by Alzheimer's disease.

G J Bosman1, F P Van Workum, K Renkawek, P J Van Kalmthout, I G Bartholomeus, W J De Grip.   

Abstract

Proteins immunologically related to the human erythrocyte anion transporter band 3 are present in neurons of the human neocortex and hippocampus. Immunocytochemical studies show increased band 3 immunoreactivity in neurons in the brains of patients with Alzheimer's disease. Immunoblot studies show the presence of band 3-like molecules in brain membrane fractions, and suggest changes in expression and/or processing of band 3-like molecules in Alzheimer's disease-affected regions. We postulate that alterations in membrane-bound, band 3-like molecules may reflect termination of neuronal lifespan in Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8256585     DOI: 10.1007/bf00369447

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  30 in total

Review 1.  Structure and function of the red blood cell anion transport protein.

Authors:  M L Jennings
Journal:  Annu Rev Biophys Biophys Chem       Date:  1989

Review 2.  Alzheimer's disease: the amyloid cascade hypothesis.

Authors:  J A Hardy; G A Higgins
Journal:  Science       Date:  1992-04-10       Impact factor: 47.728

Review 3.  Molecular biology of the anion exchanger gene family.

Authors:  R R Kopito
Journal:  Int Rev Cytol       Date:  1990

4.  Desensitization of gamma-aminobutyric acid receptor from rat brain: two distinguishable receptors on the same membrane.

Authors:  D J Cash; K Subbarao
Journal:  Biochemistry       Date:  1987-12-01       Impact factor: 3.162

Review 5.  Alzheimer's disease: a cell biological perspective.

Authors:  K S Kosik
Journal:  Science       Date:  1992-05-08       Impact factor: 47.728

6.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

Authors:  S M Hsu; L Raine; H Fanger
Journal:  J Histochem Cytochem       Date:  1981-04       Impact factor: 2.479

7.  Diagnosis of Alzheimer's disease.

Authors:  Z S Khachaturian
Journal:  Arch Neurol       Date:  1985-11

8.  Identification of immunoreactive forms of human erythrocyte band 3 in nonerythroid cells.

Authors:  D Drenckhahn; K Zinke; U Schauer; K C Appell; P S Low
Journal:  Eur J Cell Biol       Date:  1984-05       Impact factor: 4.492

9.  Does Alzheimer's disease represent an exaggeration of normal aging?

Authors:  L Berg
Journal:  Arch Neurol       Date:  1985-08

10.  Distinctive, rapid, and easy labeling of diffuse plaques in the Alzheimer brains by a new methenamine silver stain.

Authors:  H Yamaguchi; C Haga; S Hirai; Y Nakazato; K Kosaka
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

View more
  2 in total

1.  Molecular characterization of anion exchangers in the cochlea.

Authors:  U Zimmermann; I Köpschall; K Rohbock; G J Bosman; H P Zenner; M Knipper
Journal:  Mol Cell Biochem       Date:  2000-02       Impact factor: 3.396

Review 2.  The biochemistry of Alzheimer's disease.

Authors:  G J Stege; G J Bosman
Journal:  Drugs Aging       Date:  1999-06       Impact factor: 3.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.